Cue Biopharma, Inc. (CUE)
26.96
-1.48
(-5.20%)
USD |
NASDAQ |
Sep 02, 16:00
26.88
-0.08
(-0.30%)
After-Hours: 20:00
Cue Biopharma Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | -0.121M |
| December 31, 2025 | 7.02M |
| September 30, 2025 | -6.768M |
| June 30, 2025 | -0.027M |
| March 31, 2025 | -0.15M |
| December 31, 2024 | -0.001M |
| September 30, 2024 | 0.098M |
| June 30, 2024 | -0.01M |
| March 31, 2024 | -0.055M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 5.00M |
| June 30, 2023 | 5.00M |
| March 31, 2023 | 15.00M |
| December 31, 2022 | 4.999M |
| September 30, 2022 | -29.52M |
| June 30, 2022 | -0.062M |
| March 31, 2022 | -0.027M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0005M |
| September 30, 2021 | -0.011M |
| June 30, 2021 | -0.233M |
| March 31, 2021 | 9.352M |
| December 31, 2020 | 9.892M |
| September 30, 2020 | 4.654M |
| June 30, 2020 | -0.14M |
| March 31, 2020 | -9.95M |
| December 31, 2019 | -15.15M |
| September 30, 2019 | 3.984M |
| June 30, 2019 | 5.127M |
| March 31, 2019 | 9.481M |
| December 31, 2018 | 4.687M |
| September 30, 2018 | -23.61M |
| June 30, 2018 | -0.76M |
| March 31, 2018 | -0.673M |
| December 31, 2017 | -0.0189M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Fortress Biotech, Inc. | -0.079M |
| Equillium, Inc. | -0.071M |
| Legend Biotech Corp. | -120.10M |
| Nurix Therapeutics, Inc. | 93.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.00M |
| Cash from Financing (Quarterly) | 30.02M |
| Free Cash Flow | -50.17M |
| Free Cash Flow Per Share (Quarterly) | -4.574 |
| Free Cash Flow to Equity (Quarterly) | -34.37M |
| Free Cash Flow to Firm (Quarterly) | -29.00M |
| Free Cash Flow Yield | -40.91% |